About Spastic paraplegia-optic atrophy-neuropathy syndrome
Spastic paraplegia-optic atrophy-neuropathy syndrome is a rare disease catalogued by Orphanet (ORPHA:320406). It is associated with the FLRT1, KLC2 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Spastic paraplegia-optic atrophy-neuropathy syndrome trials.
Search ClinicalTrials.gov for "Spastic paraplegia-optic atrophy-neuropathy syndrome" or filter by Orphanet code ORPHA:320406 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Spastic paraplegia-optic atrophy-neuropathy syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Spastic paraplegia-optic atrophy-neuropathy syndrome. Updated daily.